The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
COLET (NCT02322814): A multistage, phase 2 study evaluating the safety and efficacy of cobimetinib (C) in combination with paclitaxel (P) as first-line treatment for patients (pts) with metastatic triple-negative breast cancer (TNBC).
 
David Miles
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech
 
Sung-Bae Kim
No Relationships to Disclose
 
V. A. McNally
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Brian P. Simmons
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Matthew Wongchenko
Employment - Genentech
Stock and Other Ownership Interests - ARIAD; Roche
 
Jessie J. Hsu
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Adam M. Brufsky
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Research Funding - Genentech